Bioregenx (BRGX) Net Cash Flow (2022 - 2026)
Bioregenx's quarterly Net Cash Flow came in at -$23577.0 in Q1 2026, down 186.43% year-on-year from $27280.0 in Q1 2025, and down 205.09% quarter-over-quarter from $22436.0 in Q4 2025.
Bioregenx has reported Net Cash Flow for 5 years, with the latest figure at -$23577.0 in Q1 2026.
- For the quarter ending Q1 2026, Net Cash Flow fell 186.43% year-over-year to -$23577.0; the trailing twelve-month figure through Mar 2026 stood at -$37844.0 (down 24.45% YoY), and the FY2025 full-year result was $13013.0, up 118.6% from the prior year.
- Net Cash Flow for Q1 2026 stood at -$23577.0, down from $22436.0 in the prior quarter.
- The five-year high for Net Cash Flow was $68381.0 in Q4 2023, with the low at -$239056.0 in Q2 2023.
- Average Net Cash Flow over 5 years is -$36135.5, with a median of -$12285.0 recorded in 2024.
- Peak annual rise in Net Cash Flow reached 8005.32% in 2023, while the deepest fall reached 28655.33% in 2023.
- Tracing BRGX's Net Cash Flow over 5 years: stood at -$865.0 in 2022, then surged by 8005.32% to $68381.0 in 2023, then plunged by 122.89% to -$15653.0 in 2024, then jumped by 243.33% to $22436.0 in 2025, then slumped by 205.09% to -$23577.0 in 2026.
- The last three Net Cash Flow figures came in at -$23577.0 (Q1 2026), $22436.0 (Q4 2025), and -$6731.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | -238.95 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | 800.32 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | -53.56 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | -21.68 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | 154.34 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | -14.11 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | 16.39 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | -60.16 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | 41.02 Mn |
| 10 | Bioregenx | - | - | 348,288.00 | -23,577.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23,577.00 |
| Mar 31, 2026 | -23,577.00 |
| Dec 31, 2025 | 22,436.00 |
| Dec 31, 2025 | 22,436.00 |
| Sep 30, 2025 | -6,731.00 |
| Sep 30, 2025 | -6,731.00 |
| Jun 30, 2025 | -29,972.00 |
| Jun 30, 2025 | -29,972.00 |
| Mar 31, 2025 | 27,280.00 |
| Mar 31, 2025 | 27,280.00 |
| Dec 31, 2024 | -15,653.00 |
| Dec 31, 2024 | -15,653.00 |
| Sep 30, 2024 | 15,246.00 |
| Sep 30, 2024 | 15,246.00 |
| Jun 30, 2024 | -57,282.00 |
| Jun 30, 2024 | -57,282.00 |
| Mar 31, 2024 | -12,285.00 |
| Mar 31, 2024 | -12,285.00 |
| Dec 31, 2023 | 68,381.00 |
| Dec 31, 2023 | 68,381.00 |
| Sep 30, 2023 | -167,356.00 |
| Sep 30, 2023 | -167,356.00 |
| Jun 30, 2023 | -239,056.00 |
| Jun 30, 2023 | -239,056.00 |
| Mar 31, 2023 | -172,053.00 |
| Mar 31, 2023 | -172,053.00 |
| Dec 31, 2022 | -865.00 |
| Dec 31, 2022 | -865.00 |
| Sep 30, 2022 | -582.00 |
| Sep 30, 2022 | -582.00 |
| Jun 30, 2022 | -1,315.00 |
| Jun 30, 2022 | -1,315.00 |
| Mar 31, 2022 | -20,920.00 |
| Mar 31, 2022 | -20,920.00 |